expert perspectives

in Multiple Myeloma

Expert Perspectives in Multiple Myeloma to Cover Key Topics in Multiple Myeloma Treatment

Overview

Expert Perspectives delivers health care providers with insights from key thought leaders on the latest advancements and current practices in medicine, in a concise and timely format. This issue of Expert Perspectives in Multiple Myeloma will feature selected topics in Multiple Myeloma that we hope you will find of value in your clinical practice.

The clinicians who were surveyed selected the following experts and topics.

Community-Selected Experts: 

Kenneth C. Anderson, MD

Kraft Family Professor of Medicine
Harvard Medical School
Director, LeBow Institute for Myeloma Therapeutics
Director, Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
Boston, MA

Sagar Lonial, MD, FACP

Chair and Professor
Department of Hematology and Medical Oncology
Anne and Bernard Gray Family Chair in Cancer
Chief Medical Officer
Winship Cancer Institute
Emory University School of Medicine
Atlanta, GA

S. Vincent Rajkumar, MD

Edward W. and Betty Knight Scripps Professor of Medicine
Mayo Clinic
Rochester, MN


Community-Selected Topics: 

Expert Roundtables 

    Review of Recent Approvals for Relapsed/Refractory Multiple Myeloma
    Effective Triplets for Non–Transplant-Eligible Patients With Multiple Myeloma
    Recommended Maintenance Therapy for Multiple Myeloma: Transplant and Nontransplant Settings
    Immune Activation in Multiple Myeloma and Roles for the Immunomodulatory Agents  

Clinical Topic Updates 

    Pairing of Immunomodulatory Agents With Proteasome Inhibitors in Multiple Myeloma
    Continuous Antimyeloma Therapy and Optimal Use of the Immunomodulatory Agents
    Updates on Driver Mutations in Relapsed/Refractory Multiple Myeloma
    Updates on Smoldering Multiple Myeloma

Patient Care Perspectives

    All-Oral Doublet and Triplet Strategies for Multiple Myeloma
    Risk-Adapted Post-Transplant Maintenance Therapy in Multiple Myeloma
    Safety and Tolerability of Long-term Continuous Treatment for Multiple Myeloma
    Multiple Myeloma: Proceeding to a Second-Generation Immunomodulatory Agent  

More in Multiple Myeloma

Thumb

Multiple Myeloma

Clinical Recommendations for the Treatment of Elderly or Frail Patients With Multiple Myeloma

Patient Care Perspectives by Carol Ann Huff, MD

Optimizing the care of older patients with multiple myeloma involves striking a balance between efficacy and toxicity. It also involves a deep unde...READ MORE

Thumb

Multiple Myeloma

Treatment Protocols for Patients With Multiple Myeloma Who Relapse After Transplant

Clinical Topic Updates by James R. Berenson, MD

While most patients with multiple myeloma will achieve disease control with autologous stem cell transplant (ASCT), virtually all of these individu...READ MORE

Thumb

Multiple Myeloma

Quality of Life and Supportive Care for Patients With Multiple Myeloma

Patient Care Perspectives by James R. Berenson, MD

Owing to significant bone pain, vulnerability to infection, fatigue, and other symptomatology related—and unrelated—to multiple myeloma, the diseas...READ MORE

More In Oncology

GIST

Gastrointestinal Stromal Tumors: Managing Side Effects of Targeted Therapies

Expert Roundtables
by Michael C. Heinrich, MD; Arun Singh, MD; and Jonathan C. Trent, MD, PhD

GIST

Optimization of Therapeutic Strategies for Patients With Gastrointestinal Stromal Tumors

Expert Roundtables
by Michael C. Heinrich, MD; Arun Singh, MD; and Jonathan C. Trent, MD, PhD

GIST

The Impact of Gastrointestinal Stromal Tumors on Quality of Life

Patient Care Perspectives
by Jonathan C. Trent, MD, PhD